BDTX

Black Diamond Therapeutics Stock Analysis

AI Rating

Good
  • Quality1/10
  • Growth↑ 7/10
  • Value↓ 4/10
Black Diamond Therapeutics sales and earnings growth
BDTX Growth
Good
  • Revenue Y/Y↓ -100.00%
  • EPS Y/Y↓ -1062.50%
  • FCF Y/Y↓ -374.02%
Black Diamond Therapeutics gross and profit margin trends
BDTX Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↓ -39.56%
Black Diamond Therapeutics net debt vs free cash flow
BDTX Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Black Diamond Therapeutics stock volatility is higher than the overall market. We give it a Great risk rating.

↗ More Biotechnology stocks